Literature DB >> 18087040

Regulation of p53 tetramerization and nuclear export by ARC.

Roger S-Y Foo1, Young-Jae Nam, Marc Jason Ostreicher, Mark D Metzl, Russell S Whelan, Chang-Fu Peng, Anthony W Ashton, Weimin Fu, Kartik Mani, Suet-Feung Chin, Elena Provenzano, Ian Ellis, Nichola Figg, Sarah Pinder, Martin R Bennett, Carlos Caldas, Richard N Kitsis.   

Abstract

Inactivation of the transcription factor p53 is central to carcinogenesis. Yet only approximately one-half of cancers have p53 loss-of-function mutations. Here, we demonstrate a mechanism for p53 inactivation by apoptosis repressor with caspase recruitment domain (ARC), a protein induced in multiple cancer cells. The direct binding in the nucleus of ARC to the p53 tetramerization domain inhibits p53 tetramerization. This exposes a nuclear export signal in p53, triggering Crm1-dependent relocation of p53 to the cytoplasm. Knockdown of endogenous ARC in breast cancer cells results in spontaneous tetramerization of endogenous p53, accumulation of p53 in the nucleus, and activation of endogenous p53 target genes. In primary human breast cancers with nuclear ARC, p53 is almost always WT. Conversely, nearly all breast cancers with mutant p53 lack nuclear ARC. We conclude that nuclear ARC is induced in cancer cells and negatively regulates p53.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18087040      PMCID: PMC2409226          DOI: 10.1073/pnas.0710017104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  The ins and outs of p53.

Authors:  K H Vousden; G F Vande Woude
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

2.  The MDM2 RING-finger domain is required to promote p53 nuclear export.

Authors:  R K Geyer; Z K Yu; C G Maki
Journal:  Nat Cell Biol       Date:  2000-09       Impact factor: 28.824

3.  An intact HDM2 RING-finger domain is required for nuclear exclusion of p53.

Authors:  S D Boyd; K Y Tsai; T Jacks
Journal:  Nat Cell Biol       Date:  2000-09       Impact factor: 28.824

4.  A bipartite nuclear localization signal is required for p53 nuclear import regulated by a carboxyl-terminal domain.

Authors:  S H Liang; M F Clarke
Journal:  J Biol Chem       Date:  1999-11-12       Impact factor: 5.157

5.  Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.

Authors:  Muyang Li; Christopher L Brooks; Foon Wu-Baer; Delin Chen; Richard Baer; Wei Gu
Journal:  Science       Date:  2003-12-12       Impact factor: 47.728

6.  Parc: a cytoplasmic anchor for p53.

Authors:  Anatoly Y Nikolaev; Muyang Li; Norbert Puskas; Jun Qin; Wei Gu
Journal:  Cell       Date:  2003-01-10       Impact factor: 41.582

7.  Regulation of p53 localization and activity by Ubc13.

Authors:  Aaron Laine; Ivan Topisirovic; Dayong Zhai; John C Reed; Katherine L B Borden; Ze'ev Ronai
Journal:  Mol Cell Biol       Date:  2006-09-25       Impact factor: 4.272

8.  Identification of p53 sequence elements that are required for MDM2-mediated nuclear export.

Authors:  J Gu; L Nie; D Wiederschain; Z M Yuan
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

Review 9.  p53 in health and disease.

Authors:  Karen H Vousden; David P Lane
Journal:  Nat Rev Mol Cell Biol       Date:  2007-04       Impact factor: 94.444

Review 10.  Exploiting the p53 pathway for the diagnosis and therapy of human cancer.

Authors:  D P Lane
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2005
View more
  43 in total

1.  Tethering function of the caspase cleavage fragment of Golgi protein p115 promotes apoptosis via a p53-dependent pathway.

Authors:  Poh Choo How; Dennis Shields
Journal:  J Biol Chem       Date:  2010-12-08       Impact factor: 5.157

2.  Cancer-associated p53 tetramerization domain mutants: quantitative analysis reveals a low threshold for tumor suppressor inactivation.

Authors:  Rui Kamada; Takao Nomura; Carl W Anderson; Kazuyasu Sakaguchi
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

3.  Expression of ARC (apoptosis repressor with caspase recruitment domain), an antiapoptotic protein, is strongly prognostic in AML.

Authors:  Bing Z Carter; Yi Hua Qiu; Nianxiang Zhang; Kevin R Coombes; Duncan H Mak; Deborah A Thomas; Farhad Ravandi; Hagop M Kantarjian; Erich Koller; Michael Andreeff; Steven M Kornblau
Journal:  Blood       Date:  2010-11-01       Impact factor: 22.113

Review 4.  Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease.

Authors:  Dominic P Del Re; Dulguun Amgalan; Andreas Linkermann; Qinghang Liu; Richard N Kitsis
Journal:  Physiol Rev       Date:  2019-10-01       Impact factor: 37.312

5.  Rab-like protein 1 A is upregulated by cisplatin treatment and partially inhibits chemoresistance by regulating p53 activity.

Authors:  Changjin Chen; Ziyi Zhao; Shiyun Tang; Cuiwei Zhang
Journal:  Oncol Lett       Date:  2018-07-24       Impact factor: 2.967

6.  p53 oligomerization status modulates cell fate decisions between growth, arrest and apoptosis.

Authors:  Nicholas W Fischer; Aaron Prodeus; David Malkin; Jean Gariépy
Journal:  Cell Cycle       Date:  2016-10-18       Impact factor: 4.534

7.  Regulation of redox signaling by selenoproteins.

Authors:  Wayne Chris Hawkes; Zeynep Alkan
Journal:  Biol Trace Elem Res       Date:  2010-03-20       Impact factor: 3.738

8.  Specific acetylation of p53 by HDAC inhibition prevents DNA damage-induced apoptosis in neurons.

Authors:  Camille Brochier; Gretel Dennis; Mark A Rivieccio; Kathryn McLaughlin; Giovanni Coppola; Rajiv R Ratan; Brett Langley
Journal:  J Neurosci       Date:  2013-05-15       Impact factor: 6.167

Review 9.  Cytoplasmic functions of the tumour suppressor p53.

Authors:  Douglas R Green; Guido Kroemer
Journal:  Nature       Date:  2009-04-30       Impact factor: 49.962

10.  Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes.

Authors:  Marie L Hertle; Claudia Popp; Sabine Petermann; Sabine Maier; Elisabeth Kremmer; Roland Lang; Jörg Mages; Bettina Kempkes
Journal:  PLoS Pathog       Date:  2009-07-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.